BIOMAT Database Logo BIOMAT Database Logo

Combination of human fibroblast and immune interferon in chronic active hepatitis B. 1987

W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Combination therapy of glycyrrhizin withdrawal and human fibroblast interferon for chronic hepatitis B.
January 1989, Clinical therapeutics,
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Administration of human fibroblast interferon in chronic hepatitis-B infection.
September 1976, Lancet (London, England),
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Fibroblast interferon in HBsAg-positive chronic active hepatitis.
December 1977, Lancet (London, England),
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.
February 1978, Gut,
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Human lymphoblastoid and fibroblast interferon in the treatment of chronic hepatitis B.
January 1990, Clinical therapeutics,
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
[Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
July 1988, Fortschritte der Medizin,
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B.
April 2001, Digestive diseases and sciences,
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Interferon in chronic active hepatitis B. Preliminary results.
June 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Interferon in chronic active hepatitis B: preliminary results.
July 1989, Journal of chemotherapy (Florence, Italy),
W H Caselmann, and P H Hofschneider, and R Koshy, and J Eisenburg
Combination therapy with hepatitis B vaccine and interferon alfa in chronic hepatitis B.
March 1999, The American journal of gastroenterology,
Copied contents to your clipboard!